TCG Crossover Management »

Alx Oncology Hldgs shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 13M 2.01

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Dianthus Therapeutics Comm (DNTH)
Tyra Biosciences Comm (TYRA)
Immunovant Comm (IMVT)
Biocryst Pharmaceuticals Comm (BCRX)
Mirum Pharmaceuticals Comm (MIRM)
Vor Biopharma Comm (VOR)
Spyre Therapeutics Comm (SYRE)
Amylyx Pharmaceuticals Comm (AMLX)
Disc Medicine Comm (IRON)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Alx Oncology Hldgs

RA Capital Management
TCG Crossover Management
venBio Partners
Redmile Group
Blackstone Group
Vanguard Capital Management
Vivo Capital
Almitas Capital
5AM Venture Management
OrbiMed Advisors
Millennium Management
Vanguard Group
Two Sigma Investments
Squadron Capital Management
Driehaus Capital Management

View all funds holding Alx Oncology Hldgs